Thus, it is needed to further investigate the role of apolipoproteins in breast cancer progression in order to answer the question if it is clinically relevant to assay for Apo B levels to predict risk of both BCR and cardiovascular disease in breast cancer patients. The gene discussed is APOB; the disease is cardiovascular disorder.